Zitrabax contains Letrozole, a powerful aromatase inhibitor primarily used to address infertility caused by anovulation by blocking estrogen production to induce ovulation. This medication effectively triggers the body to increase hormone production when estrogen levels drop, promoting ovulation in women experiencing ovulatory infertility. Additionally, Zitrabax is beneficial in cases of unexplained infertility as a standalone treatment. Beyond fertility, Zitrabax is prescribed for hormone receptor-positive breast cancer in postmenopausal women or those who have undergone prior cancer therapies, as it suppresses estrogen that fuels cancer growth. This dual-use pharmaceutical enhances reproductive health and provides crucial support in breast cancer management for a specific patient subset.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Letrozole |
| Primary Use | Treatment of infertility caused by anovulation and unexplained infertility |
| Secondary Use | Hormone therapy for postmenopausal breast cancer patients |
| Mechanism of Action | Blocks estrogen production to stimulate ovulation and inhibit estrogen-driven cancer cell growth |
| Target Patient Group | Women facing infertility due to ovulation issues and postmenopausal breast cancer patients |
| Administration | Oral medication |
| Therapeutic Category | Gynecological and oncological treatment |
| Usage | Can be used alone or post other cancer treatments |
| Regulatory Status | Prescription-only medication |
| Treatment Outcome | Induces ovulation and slows breast cancer progression |
| Attributes | Description |
|---|---|
| Dosage Form | Tablet |
| Dosage Strength | Typically available in 2.5 mg tablets (confirm exact dosage as per batch) |
| Route of Administration | Oral |
| Packaging | Blister pack or bottle (specific packaging details vary by supplier) |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Shelf Life | Usually 2-3 years, depending on manufacturer |
| Prescription Requirement | Mandatory prescription required for purchase |
| Manufacturer | Information varies; verify with supplier |
| Therapeutic Class | Aromatase inhibitor |
| Contraindications | Not for use in premenopausal women except under specialist supervision |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Yes, Zitrabax (Letrozole) is also effective for unexplained infertility, making it useful in cases where ovulation is not clearly impaired.
Zitrabax is typically prescribed for postmenopausal women and may not be suitable for premenopausal breast cancer patients without specialist supervision.
Zitrabax suppresses estrogen production, which can slow or inhibit the growth of hormone receptor-positive breast cancer cells in postmenopausal women.
Zitrabax can be used alone or in conjunction with other infertility therapies, but treatment plans should be managed by a healthcare professional.
Store Zitrabax tablets in a cool, dry place away from direct sunlight to maintain potency and shelf life.
Brand: baxton india
Country Of Origin: India
When infertility is caused by a lack of ovulation, letrozole works by blocking the production of estrogen; doing so triggers ovulation as the body senses a low estrogen level and increases hormone production. Letrozole can be used alone in ovulatory infertility, and it can be used in unexplained infertility
Letrozole is used to treat certain types of breast cancer in women who have already stopped menstruating (postmenopausal). It is also used for women who have already had other cancer treatments
